Chad Pollio
About Chad Pollio
Chad Pollio serves as the Director of Business Development at Celerion, bringing extensive experience in clinical pharmacology research and study services. His career includes significant roles at ICON Development Solutions and Spaulding Clinical, where he focused on first-in-human studies and cardiovascular safety.
Current Role at Celerion
Chad Pollio serves as the Director of Business Development at Celerion, a position he has held since 2016. His role involves overseeing business development strategies and initiatives within the organization, which is based in High Point, North Carolina. Pollio's extensive experience in clinical pharmacology research enhances his ability to contribute to Celerion's mission of providing high-quality clinical research services.
Previous Experience in Business Development
Prior to his current position, Chad Pollio worked at ICON Development Solutions as Director of Business Development from 2003 to 2014. He spent 11 years in this role, where he focused on expanding business opportunities. Following his tenure at ICON, he served as Director of Business Development at Spaulding Clinical from 2014 to 2016, further solidifying his expertise in the field.
Educational Background
Chad Pollio completed his Bachelor of Science in Health Sciences at James Madison University from 1991 to 1995. He furthered his education by obtaining a Master of Public Health in Epidemiology from the University of Alabama at Birmingham, studying from 1996 to 1998. His educational background provides a strong foundation for his work in clinical pharmacology and business development.
Expertise in Clinical Pharmacology Research
Chad Pollio possesses extensive experience in clinical pharmacology research, particularly in first-in-human and clinical proof of concept studies. His expertise includes providing full study services that encompass statistics, data management, and biostatistics, with a specific focus on pharmacokinetics/pharmacodynamics (PK/PD) analysis and bioanalytical services. Additionally, he has a strong background in cardiovascular safety and NDA-enabling clinical pharmacology research.
Early Career Experience
Before transitioning into business development, Chad Pollio worked as a Data Manager at The Stanley Foundation from 1998 to 2001. This role provided him with valuable experience in data management, which has been beneficial throughout his career in clinical research and business development.